TTV viral load as a predictor of antibody response to SARS COV-2 vaccination

Daniele Focosi; Andreina Baj; Lorenzo Azzi; Federica Novazzi; Fabrizio Maggi

doi:10.1016/j.healun.2022.10.025

TTV viral load as a predictor of antibody response to SARS COV-2 vaccination

J Heart Lung Transplant. 2023 Feb;42(2):143-144. doi: 10.1016/j.healun.2022.10.025. Epub 2022 Nov 6.

Authors

Daniele Focosi¹, Andreina Baj², Lorenzo Azzi², Federica Novazzi², Fabrizio Maggi³

Affiliations

¹ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: [email protected].
² Department of Medicine and Surgery, University of Insubria.
³ National Institute for Infectious Diseases "L. Spallanzani", Roma, Italy.

Abstract

The measure of torquetenovirus (TTV) viremia is widely recognized as an optimal biomarker of an individual immune status. In the context of COVID-19, the predictive role of TTV load with regard to vaccine response has also been demonstrated, suggesting other intriguing applications for this widespread anellovirus.

Keywords: COVID-19; TTV; immune response; torquetenovirus; vaccine.

Publication types

Editorial

MeSH terms

Antibody Formation
COVID-19* / prevention & control
DNA Virus Infections*
Humans
Torque teno virus*
Vaccination
Viral Load